(Q40721679)

23 September 2017

title

Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives (English)

1 reference

23 September 2017

1 reference

Hundscheid RD

1

1 reference

23 September 2017

Braat DD

2

1 reference

23 September 2017

Kiemeney LA

3

1 reference

23 September 2017

Smits AP

4

1 reference

23 September 2017

Thomas CM

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

16

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

457-462

1 reference

Pituitary and ovarian function in women receiving hormonal contraception

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Association between idiopathic premature ovarian failure and fragile X premutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Reproductive and menstrual history of females with fragile X expansions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.3.457

21 January 2018

Identifiers

DOI

10.1093/HUMREP/16.3.457

1 reference

23 September 2017

1 reference